Clinical Trials Browser

Phase 1/2 × OTHER × Estramustine × Clear all

NCT00038246 2018-10-31

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

Phase 1/2 Completed

40 enrolled

Genitourinary

Prostatic Neoplasms

NCT00151086 2015-01-22

Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

Phase 1/2 Completed

33 enrolled

Genitourinary

Prostatic Neoplasms

NCT00004105 2011-03-28

Combination Chemotherapy in Treating Patients With Advanced Cancer

Phase 1/2 Completed

LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fibrosarcoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00132756 2006-11-08

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Phase 1/2 Terminated

30 enrolled

Genitourinary

Prostatic Neoplasms